澳洋健康：公司股票将继续停牌

Core Viewpoint - Aoyang Health (002172) announced on September 10 that its controlling shareholder, Aoyang Group, is planning to transfer company shares, with ongoing negotiations for the overall transaction scheme [1] Group 1 - As of the announcement date, the parties involved have not yet signed a formal agreement and are actively preparing for the transaction [1] - The company expects that it will not be able to resume trading on September 11, 2025, at the market opening [1] - The company's stock will continue to be suspended from trading starting September 11, 2025, with an expected suspension period of no more than three trading days [1]